Sinopharm subsidiary revenue up 3.5% but profit falls 6.9%

Sinopharm Group reported mixed interim results for subsidiary SINOPHARM (CNCM LTD) for the six months ended June 30, 2025.

Revenue increased 3.54% to RMB 25.6 billion, but total profit declined 6.92% to RMB 1.2 billion. Net profit attributable to shareholders fell 5.19% to RMB 948.5 million.

Basic earnings per share dropped to RMB 1.26 from RMB 1.33, while weighted average return on net assets decreased 0.78 percentage points to 5.45%.